Literature DB >> 11702084

5-HT6 receptor antagonists enhance retention of a water maze task in the rat.

D C Rogers1, J J Hagan.   

Abstract

RATIONALE: 5-HT(6) receptors are predominantly located in the brain and may be involved in cognitive processes. The aim of this study was to assess the effects of two potent and selective 5-HT(6) receptor antagonists, SB-271046-A and SB-357134-A, on learning and memory in the rat.
METHODS: Spatial learning and memory was assessed by testing the effects of SB-271046-A and SB-357134-A on acquisition and retention of a water maze task.
RESULTS: In the water maze, administration of SB-271046-A or SB-357134-A (3 or 10 mg/kg) had no effect on learning per se. At 10 mg/kg, however, both compounds produced a significant improvement in retention of a previously learned platform position when tested 7 days after training. By contrast, the acetylcholinesterase inhibitor, Aricept (donepezil, 0.1, 0.3 mg/kg PO) had no effect in this task.
CONCLUSIONS: This study demonstrates that systemic administration of SB-271046-A and SB-357134-A produces improvements in retention of a water maze task in the rat. These data indicate that 5-HT(6) receptor antagonism may be involved in cognitive function.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11702084     DOI: 10.1007/s002130100840

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  25 in total

1.  Biodistribution and radiation dosimetry of the serotonin 5-HT₆ ligand [¹¹C]GSK215083 determined from human whole-body PET.

Authors:  Robert A Comley; Cristian Salinas; Romina Mizrahi; Irina Vitcu; Alvina Ng; William Hallett; Nicholas Keat; Alan A Wilson; Eugenii A Rabiner; Marc Laruelle; Sylvain Houle
Journal:  Mol Imaging Biol       Date:  2012-08       Impact factor: 3.488

2.  Increased impulsivity and disrupted attention induced by repeated phencyclidine are not attenuated by chronic quetiapine treatment.

Authors:  Nurith Amitai; Athina Markou
Journal:  Pharmacol Biochem Behav       Date:  2008-09-08       Impact factor: 3.533

Review 3.  Alzheimer's disease and age-related memory decline (preclinical).

Authors:  Alvin V Terry; Patrick M Callahan; Brandon Hall; Scott J Webster
Journal:  Pharmacol Biochem Behav       Date:  2011-02-24       Impact factor: 3.533

4.  5-HT6 receptor blockade differentially affects scopolamine-induced deficits of working memory, recognition memory and aversive learning in mice.

Authors:  Virginie Da Silva Costa-Aze; Anne Quiedeville; Michel Boulouard; François Dauphin
Journal:  Psychopharmacology (Berl)       Date:  2012-02-25       Impact factor: 4.530

5.  The effects of PRX-07034, a novel 5-HT6 antagonist, on cognitive flexibility and working memory in rats.

Authors:  Eric G Mohler; Phillip M Baker; Kimberly S Gannon; Simon S Jones; Sharon Shacham; John A Sweeney; Michael E Ragozzino
Journal:  Psychopharmacology (Berl)       Date:  2011-10-12       Impact factor: 4.530

6.  Dorsomedial prefrontal cortex 5-HT6 receptors regulate anxiety-like behavior.

Authors:  Fei Geng; Jia Tian; Jian-Lin Wu; Yun Luo; Wen-Jun Zou; Chao Peng; Gui-Feng Lu
Journal:  Cogn Affect Behav Neurosci       Date:  2018-02       Impact factor: 3.282

7.  Antidepressant and anxiolytic effects of selective 5-HT6 receptor agonists in rats.

Authors:  Gregory V Carr; Lee E Schechter; Irwin Lucki
Journal:  Psychopharmacology (Berl)       Date:  2010-03-09       Impact factor: 4.530

Review 8.  A pharmacological analysis of an associative learning task: 5-HT(1) to 5-HT(7) receptor subtypes function on a pavlovian/instrumental autoshaped memory.

Authors:  Alfredo Meneses
Journal:  Learn Mem       Date:  2003 Sep-Oct       Impact factor: 2.460

9.  Effects of 5-HT6 receptor antagonism and cholinesterase inhibition in models of cognitive impairment in the rat.

Authors:  B Marcos; T T Chuang; F J Gil-Bea; M J Ramirez
Journal:  Br J Pharmacol       Date:  2008-07-14       Impact factor: 8.739

Review 10.  5-HT6 receptor antagonists as novel cognitive enhancing agents for Alzheimer's disease.

Authors:  Neil Upton; Tsu Tshen Chuang; Ann J Hunter; David J Virley
Journal:  Neurotherapeutics       Date:  2008-07       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.